Citigroup’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.9M Buy
864,111
+623,275
+259% +$16.5M 0.01% 675
2025
Q1
$5.82M Buy
240,836
+62,189
+35% +$1.5M ﹤0.01% 1285
2024
Q4
$7.19M Buy
178,647
+49,302
+38% +$1.98M ﹤0.01% 1165
2024
Q3
$8.19M Buy
129,345
+30,957
+31% +$1.96M ﹤0.01% 1030
2024
Q2
$5.22M Sell
98,388
-115,683
-54% -$6.13M ﹤0.01% 1151
2024
Q1
$17.6M Buy
214,071
+35,248
+20% +$2.89M 0.01% 675
2023
Q4
$3.33M Sell
178,823
-180,762
-50% -$3.36M ﹤0.01% 1336
2023
Q3
$3.98M Buy
359,585
+191,826
+114% +$2.12M ﹤0.01% 1140
2023
Q2
$2.72M Sell
167,759
-391,982
-70% -$6.35M ﹤0.01% 1462
2023
Q1
$9.32M Buy
559,741
+431,531
+337% +$7.18M 0.01% 872
2022
Q4
$1.21M Buy
128,210
+122,781
+2,262% +$1.15M ﹤0.01% 1871
2022
Q3
$15K Buy
5,429
+4,466
+464% +$12.3K ﹤0.01% 4133
2022
Q2
$3K Sell
963
-4,226
-81% -$13.2K ﹤0.01% 5015
2022
Q1
$16K Sell
5,189
-183,270
-97% -$565K ﹤0.01% 4531
2021
Q4
$867K Buy
188,459
+94,365
+100% +$434K ﹤0.01% 2680
2021
Q3
$591K Sell
94,094
-195,071
-67% -$1.23M ﹤0.01% 2785
2021
Q2
$1.73M Sell
289,165
-143,347
-33% -$859K ﹤0.01% 2191
2021
Q1
$2.74M Buy
432,512
+415,276
+2,409% +$2.63M ﹤0.01% 1738
2020
Q4
$97K Buy
17,236
+4,711
+38% +$26.5K ﹤0.01% 3696
2020
Q3
$73K Sell
12,525
-63,581
-84% -$371K ﹤0.01% 3295
2020
Q2
$548K Sell
76,106
-6,722
-8% -$48.4K ﹤0.01% 2504
2020
Q1
$388K Sell
82,828
-18,464
-18% -$86.5K ﹤0.01% 2440
2019
Q4
$812K Sell
101,292
-202,060
-67% -$1.62M ﹤0.01% 2334
2019
Q3
$2.09M Sell
303,352
-231,552
-43% -$1.59M ﹤0.01% 1588
2019
Q2
$4.44M Buy
534,904
+478,867
+855% +$3.97M ﹤0.01% 1164
2019
Q1
$557K Sell
56,037
-883,613
-94% -$8.78M ﹤0.01% 2416
2018
Q4
$7.19M Buy
939,650
+612,741
+187% +$4.69M 0.01% 839
2018
Q3
$5.69M Buy
326,909
+317,866
+3,515% +$5.54M 0.01% 940
2018
Q2
$85K Buy
+9,043
New +$85K ﹤0.01% 3541
2016
Q2
Sell
-100
Closed 5300
2016
Q1
$0 Buy
+100
New ﹤0.01% 5616